Demuth and colleagues compared KRAS mutation status of 28 patients with metastatic colorectal cancers between cfDNA and matched tumour samples with targeted sequencing and ddPCR, yielding a concordance rate of 79% and 89% for each method, respectively [75]. Here, KRAS is linked to colorectal cancer.